RxDoctor Payments Data

Chad Matsui

Family · Ewa Beach, HINPI 1215511076

Payments from drug & device makers

$552in general payments, 2019–2025

Across 26 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$141
  • GSK$82
  • Novo Nordisk$63
  • AstraZeneca$60
  • Viiv Healthcare Company$53
  • Pfizer$42
  • plus $111 from 4 others

What the payments were for

  • Food & beverage$54198%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$552 in reported general payments places this provider in the 65th percentile of 466 family providers in Hawaii.

See all family providers in Hawaii

Medicare billing

Part B allowed, 2024
$15,718
Medicare patients
70
Services billed
154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide19$42,092
JardianceEmpagliflozin12$12,232
Atorvastatin Calcium95$1,525
Losartan Potassium81$1,234
Rosuvastatin Calcium17$804
Amlodipine Besylate83$680
Omeprazole16$565
Metformin Hcl ErMetformin Hcl30$522
Mirtazapine12$479
Metoprolol Succinate22$392
Albuterol Sulfate HfaAlbuterol Sulfate14$336
ClopidogrelClopidogrel Bisulfate13$287
Gabapentin14$244
Levothyroxine Sodium40$224
Lisinopril32$221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$63$42,09219 claims
Boehringer IngelheimJardiance$141$12,23212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 466 family providers in Hawaii.

Other family in Ewa Beach

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →